The objective of this research is to characterize phenomenologically and mechanistically the complex steroid-mediated response of rat hepatoma tissue (HTC) cells to identify possible relationships to hepatic processes and to identify the factors modulating the glucocorticoid action. The overall goal is to assemble a comprehensive picture of hormonal regulation in one system that will serve as a valid and experimentally manipulatable tissue culture model for liver-specific events. Dexamethasone-mediated alterations in plasma membrane properties of HTC cells are assessed by a combination of immunoelectrophoretic analyses, and in situ labeling of externally exposed proteins, followed by two-dimensional electrophoretic separation and measurements of the uptake of metabolites. The effect on the secretion program is determined by metabolic labeling of secretory glycoproteins. To relate these effects to events in the liver, primary hepatocytes have been prepared from animals of different developmental stages and analyzed under culture conditions that maintain the phenotype at the time of isolation. To understand what factors in vivo or in tissue culture can modify the phenotypic pattern of dexamethasone action, HTC and liver cells have been tested in reconstituted culture systems or treated with possible effectors, such as interleukin-1, glucagon, or cAMP. It was possible to correlate some of the dexamethasone responses of HTC cells to specific events in the liver during acute phase reaction. At the molecular level, it was found that concentrations of several mRNAs were increased in HTC cells by glucocorticoids. Two mRNAs encoded for abundant secretory glycoproteins, one of which corresponds to gammal-acid glycoprotein (AGP), the major acute phase plasmaprotein of the rat liver. DNAs complementary to mRNAs of some dexamethasone-inducible proteins, including AGP, were cloned. These have been used as hybridization probes to measure kinetics and specificity of hormone induction in both HTC and liver cells. (A)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA026122-08
Application #
3167192
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1979-07-01
Project End
1988-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
8
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Benekli, Mustafa; Xia, Zheng; Donohue, Kathleen A et al. (2002) Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival. Blood 99:252-7
Xia, Z; Salzler, R R; Kunz, D P et al. (2001) A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blasts. Cancer Res 61:1747-53
Xia, Z; Sait, S N; Baer, M R et al. (2001) Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia. Leuk Res 25:473-82
Blanchard, F; Duplomb, L; Wang, Y et al. (2000) Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem 275:28793-801
Klausen, P; Pedersen, L; Jurlander, J et al. (2000) Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene 19:3675-83
Wang, Y; Robledo, O; Kinzie, E et al. (2000) Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. J Biol Chem 275:25273-85
Pandey, A; Ozaki, K; Baumann, H et al. (2000) Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol 1:59-64
Lai, C F; Ripperger, J; Wang, Y et al. (1999) The STAT3-independent signaling pathway by glycoprotein 130 in hepatic cells. J Biol Chem 274:7793-802
Wen, X Y; Stewart, A K; Sooknanan, R R et al. (1999) Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells. Int J Oncol 15:173-8
Isaksen, D E; Baumann, H; Trobridge, P A et al. (1999) Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol 163:5971-7

Showing the most recent 10 out of 73 publications